Larvol Delta - Formycon-AG-and-ATHOS-KG-announce-closing-of-transaction-to-acquire-biosimilar-assets-FYB201-and-FYB202-as-well-as-Bioeq-GmbH

Cimerli (ranibizumab biosimilar) - Amneal, Formycon, Coherus Biosci, Teva

FYB202 (ustekinumab biosimilar) - Formycon

https://uk.finance.yahoo.com/news/formycon-ag-athos-kg-announce-053012184.html

May 10, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next